Nano Bridging Molecules Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 7

Nano Bridging Molecules General Information

Description

Manufacturer of medical equipment intended to facilitate bone-anchored implants. The company offers medical implant coatings, a treatment that is compatible with any surface roughness or porosity, promotes osseointegration, thereby enabling customers with both early integration and long-term stability.

Contact Information

Formerly Known As
Suriasis
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Corporate Office
  • Route De Cité-Ouest 2
  • 1196 Gland
  • Switzerland
+41 022
Primary Industry
Other Devices and Supplies
Other Industries
Therapeutic Devices
Parent Company
Vertical(s)
Corporate Office
  • Route De Cité-Ouest 2
  • 1196 Gland
  • Switzerland
+41 022

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nano Bridging Molecules Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nano Bridging Molecules‘s full profile, request access.

Request a free trial

Nano Bridging Molecules Patents

Nano Bridging Molecules Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2017217275-A1 Improved treatment of implants with phosphonic acid compounds Active 12-Feb-2016
AU-2017217275-B2 Improved treatment of implants with phosphonic acid compounds Active 12-Feb-2016
CA-3013841-A1 Improved treatment of implants with phosphonic acid compounds Active 12-Feb-2016
CA-3013841-C Improved treatment of implants with phosphonic acid compounds Active 12-Feb-2016
EP-3413934-A1 Improved treatment of implants with phosphonic acid compounds Active 12-Feb-2016 A61L27/28
To view Nano Bridging Molecules’s complete patent history, request access »

Nano Bridging Molecules Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Nano Bridging Molecules‘s full profile, request access.

Request a free trial

Nano Bridging Molecules FAQs

  • When was Nano Bridging Molecules founded?

    Nano Bridging Molecules was founded in 2002.

  • Where is Nano Bridging Molecules headquartered?

    Nano Bridging Molecules is headquartered in Gland, Switzerland.

  • What industry is Nano Bridging Molecules in?

    Nano Bridging Molecules’s primary industry is Other Devices and Supplies.

  • Is Nano Bridging Molecules a private or public company?

    Nano Bridging Molecules is a Private company.

  • What is Nano Bridging Molecules’s current revenue?

    The current revenue for Nano Bridging Molecules is .

  • Who are Nano Bridging Molecules’s investors?

    Ecole Polytechnique Federale de Lausanne, Fongit, Swiss Confederation Commission for Technology and Innovation, and Venture Kick have invested in Nano Bridging Molecules.

  • When was Nano Bridging Molecules acquired?

    Nano Bridging Molecules was acquired on 01-Jan-2015.

  • Who acquired Nano Bridging Molecules?

    Nano Bridging Molecules was acquired by MIS Implants Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process